Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 4,362 | 1,811 | 4,430 | 7,600 | 2,963 |
| Gross Profit | 4,362 | 1,811 | 4,430 | 7,500 | 2,963 |
| Operating Expenses | 11,206 | 11,234 | 10,388 | 9,920 | 6,614 |
| Operating Income | -6,844 | -9,423 | -5,958 | -2,320 | -3,651 |
| Other Income | -1,760 | 3,342 | -12,026 | -290 | -2,254 |
| Pre-tax Income | -8,604 | -6,081 | -17,984 | -2,610 | -5,905 |
| Net Income Continuous | -8,604 | -6,081 | -17,984 | -2,600 | -5,905 |
| Net Income | $-8,604 | $-6,081 | $-17,984 | $-2,600 | $-5,905 |
| EPS Basic Total Ops | -0.39 | -0.28 | -0.91 | -0.15 | -0.41 |
| EPS Basic Continuous Ops | -0.39 | -0.28 | -0.91 | -0.15 | -0.41 |
| EPS Diluted Total Ops | -0.39 | -0.28 | -0.91 | -0.15 | -0.41 |
| EPS Diluted Continuous Ops | -0.39 | -0.28 | -0.91 | -0.15 | -0.41 |
| EBITDA(a) | $-6,711 | $-9,274 | $-5,824 | $-2,176 | $-3,503 |